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5Abstract
PDD is a progressive disease often fatal, that occurs in several parrot species but a
common susceptibility of all parrots is suspected. It also may occur in non psittacine bird
like, gooses, hawks, doves tucans and flamingos. The ill birds develop gastrointestinal or
central nervous system signs. These presentation can be occur like a combination of both
or alone. The clinical signs are caused by histological nervous lesions, characterized by a
non suppurative encephalomyelitis and/or perineural lymphoplasmacytic infiltrates around
peripheral nerves. The intramural neural plexa of digestive tract were constanctly involved.
The diagnosis is characterized by inconsistent clinical laboratory findings. A presumptive
diagnosis of PDD is often based on anamnestic information, contrast radiographs,
fluoroscopy in PDD suspect birds. Until now the only specific and reliable method used for
the diagnosis is the crop biopsy. The presence of characteristic histological perineural
infiltrates are strongly suggestive of the disease and necessary for a definitive diagnosis.
Until now the etiology and the pathogenesis are unclear, even if, many Authors suppose
the potential role of unclear virus as the causative agent of PDD.
The different aspects of this disease show a lot of analogies with the human Guillain Barrè
syndrome, so we have focalised the our study to clarify the pathogenesis. To do this, we
investigated if the PDD can be an autoimmune disease and if a possible presence of the
blood antiganglioside antibodies can be the starter of this autoimmune pathological
mechanism, like was observed in more than 50% of the GBS’s cases.
Keywords
Proventricular dilatation disease (PDD), antiganglioside antibodies, Guillain
Barrè syndrome, parrot
61) Compilative Part
i) Proventricular Dilatation Diesease (PDD)
a) Introduction
Proventricular dilatation disease (PDD) has been reported since the late 1970’s in USA 
(Graham, 1984; Phalen, 1986). Initially, the disease seemed to be limited to macaws. This
fact, in conjunction with an unknown clearly aetiology, gave rise to the terms macaw
wasting or fading syndrome, wasting macaw syndrome and gastric distention of macaws
(Huges, 1984; Mannl et al., 1987). Until now even if it was diagnosed in more of 50
different species of birds, the most susceptible group appear to be the psittacines (Ritchy,
2006; Kistler et al., 2008). The development of the disease is progressive, variably
contagious and often fatal. The typical clinical presentation is characterized of
gastrointestinal and central nervous system signs present both or alone in the affected
birds (Gregory, 1995). The symptoms reflect the pathognomonic microscopically lesion,
represented by lymphoplasmacytic perineural and perivascular infiltration in the trigger
organs (Berhane et al., 2001).
Several viruses have been identified in birds with PDD or in flocks where PDD was a
problem, but until now different dubts persist about the etiology (Phalen, 2006).
b) Clinical aspects
PDD occurs most frequently in african grey parrots, macaws, amazon parrots, cockatoos
and conures, but it is possible that all parrot species are susceptible (Phalen, 1994). It also
may occur in non-psittacine birds, as a disease with similar lesions has been observed in
like Canada geese, redtailed hawk, toucan, spoonbill, flamingos, hooney creeper, canary
and finch (Ritchy, 2006). There is no sex predilection for PDD. The median age of onset of
PDD is 3 to 4 years, but birds as young as 10 weeks and as old as 17 years have been
documented with lesions consistent with PDD. Domestically raised and imported birds are
equally susceptible to disease. The incubation period for this disease is not known but may
be long, as birds isolated from contact with other birds for up to 2 years still have
developed this disease (Phalen , 2006).
The clinical signs of PDD vary between individuals and species, but in general they exhibit
two general types of disease. Some develop neurologic signs such as depression,
seizures, ataxia, blindness, tremors, incoordination, slowly progressive, proprioceptive
deficits, paresis and less commonly paralysis. They may reflect disease of the brain or the
7spinal cord, and recent evidence suggests that they also may reflect lesions of the lower
motor neurons. (Phalen, 2006; . A peripheral neuritis has also been reported in some birds
involving the sciatic, brachial and vagal nerves (Berhane et al., 2001). Alternatively, birds
may develop gastrointestinal problems such as crop stasis, regurgitation, inappetance,
and undigested food in feces secondary to damage to the enteric nervous system. This
damage leads eventually to starvation and death. Death due to circulatory collapse or food
aspiration is also common. Birds may show neurologic signs or gastrointestinal signs or
both. It is also suspected that some affected birds may show minor or no clinical signs
(Villanueva et al. 2009).
Physical examination, however, reveals an emaciated bird. Often the ventriculus can be
palpated in the coelomic cavity caudal to the edge of the sternum. Radiographically, the
proventriculus is often massively dilated, filling the left side of the coelomic cavity (Fig. 1).
Contrastographic x-ray study show distention of the proventriculus and ventriculus and
often the proximal duodenum. Transit time of the contrast material is markedly reduced.
Various permutations of this disease may occur, and dilation of the crop, ventriculus,
proventriculus or duodenum may be seen alone or in combination. Typically, the stomachs
develops a “J” shape causing the ventriculus to be displaced to the right and ventraly(Fig.
2). Ultrasound will demonstrate a widely distended proventriculus and ventriculus (Phalen,
2006) and fluoroscopy has been used to demonstrate reduced gastric motility which can
be an indication of PDD (Taylor et al., 1997).
(Fig. 1) (Fig. 2)
Figure 1: Radiographic aspect of dilatated proventricula in severe affected parrots.
Figure 2: Proventricular aspect during necropsy in PDD affected bird.
c) Diagnosis
8Many clinical aspect can help the clinician to diagnosticate the disease but there are other
pathologies that can cause nearly identical signs (Antinoff, 2001). Unfortunatelly until now
the only in vivo “golden standard” examination to obtain the definitive diagnosis of this 
disease is the demonstrating of the pathognomonic microscopically lesions in a crop
biopsy, rappresented by a lymphoplasmacytic perineural and perivascular infiltration (Fig.
6-7). Not all birds with PDD have crop lesions, and the percentage of the infiltration in the
nervous structure of the crop is 40-76% (Schivaprasad et al., 1995; Gregory et al., 1997;
Berhane et al., 2001), so failure to find lesions in a biopsy does not rule out the disease. It
is suggested that biopsying the right cranial ventral aspect of the crop, while making sure
that it contains a blood vessel, will increase the probability of a lesion being found
(Gregory et al., 1998). (photo 3).
(Fig. 3)
Figure 3: Surgery procedure to obtain the crop biopsy sample.
d) Etiopathogenesis
Several viruses have been identified in birds with PDD or in flocks where PDD was a
problem. These include Eastern Equine Encephalitis, Enterovirus, Coronavirus, Reovirus,
Avian Paramyxovirus 1 and Paramyxovirus 3. (Gought and Harcourt-Brown, 1998;
Gregory, 1998, Grund et al., 2002). Recently, the use of high-throughput viral screens has
enabled investigators to identify the presence of a new virus, avian Borna virus (ABV),
from several cases of biopsy-confirmed PDD (Honkavouri et al., 2008; Villanueva et al.
2009) sequent studies using PCR and immunohistochemistry on tissues of affected birds
have confirmed the association between ABV infection and PDD.
9PCR and serological methods was used to identified the nucleoprotein p40 (De Kloet and
Dorrestein, 2009). In BDV different studies show the fact that anti-p40 antibodies are the
first virus-specific antibodies synthesized, around day 15 p.i., and the fact that the p40-
specific T-cell activity is also detectable early after infection make this virus-specific protein
a major target antigen in both the humoral and cellular immune reaction in BD (Planz, and
Stitz, 1999). The seropositivity obtained for viral nucleo-protein P40 using the Western blot
and the ELISA in apparently healthy parrots that shedding virus (De Kloet and Dorrestein,
2009; Liertz et al 2009) evidence the unclear role of this virus in the development of the
histological lesion and the subsequent associated clinical signs. Actually, the seropositivity
of “healthy” birds is dificult to explicate. 
As in most other infectious diseases, a population of seropositive healthy birds can be
expected to exist that may include infected animals before to develop disease or
recovered animals that have acquired an immune status to the disease (Villanueva et al.
2009). Until now even if different study show a high correlation between this infection and
the disease the epidemiology, the infectivity of this virus, and the pathogenesis of virus-
induced lesions still unclear.
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3) Buillan Barrè Syndrome (GBS)
a) Introduction
Guillain-Barre syndrome (GBS) is an acute demyelinating disease of peripheral nerves, an
immune-mediated disorder which usually follows viral illness or immunization (Bouyahia et
al., 2010). The immune system attacks spinal nerve roots, peripheral nerves, and cranial
nerves, resulting in focal inflammation, with variable damage to myelin sheaths and axon
fibers. Described originally by French physicians working in the Sixth Army camp during
the First World War (Guillain et al., 1916), it has remained relatively rare, but so striking in
its presentation that few doctors will not remember the clinical features. GBS is the most
common acute neuropathy of adults, and occurs worldwide at an incidence of 1 to 2 cases
per 100,000 annually (Guillain-Barré Syndrome Study Group, 1985; Rees et al. 1998; El-
Sabrout et al., 2001; Schwerer, 2002). It is slightly more common in men, by a ratio of 1.3
to 1. GBS affects all ages, with peaks among young adults and the elderly (Alter,1990).
The classic clinical picture is that of an acute ascending paralysis, with depressed/lost
deep tendon reflexes, facial weakness, and minimal sensory loss (Asbury, 1981). The
involvement of both sympathetic and parasympathetic fibers in GBS is usually observed as
extra neurological manifestations such as cardiovascular, gastrointestinal, respiratory, and
other systems (Kitamura et al., 1998; Illyas et al., 2004; Olbricht et al., 2004; Bouyahia et
al., 2010). GBS can develop very rapidly, over hours to days, but always reaches its worst
stage within 4 weeks. Although the vast majority of patients recover, 4-10% are left
severely disabled. Worse prognosis is associated with more severe disease, older age,
and very abnormal electrodiagnostic studies. The mortality rate of 3% to 8% reflects
autonomic and respiratory problems, and indicates that all but the mildest cases should be
monitored in an intensive care setting. For patients on a respirator, the mortality rate is
even higher (15% to 30%). GBS is typically monophasic, but 3% of cases experience
relapses (Kleopa, Brown personal communication). Laboratory hallmarks of GBS involve
cerebrospinal changes (elevated protein, normal cell count) which reflect damage to the
blood-cerebrospinal fluid barrier, and a series of electrodiagnostic peripheral nerve
abnormalities (slowed or blocked nerve conduction, prolonged latency, delayed or absent
F and H responses, abnormal temporal dispersal rates). GBS is associated with preceding
infection in some 70% of cases. The most commonly identified triggering agents are
Campylobacter jejuni (in 13% to 39%), followed by Cytomegalovirus (5% to 22%), Epstein
Barr virus (1% to 13%), and Mycoplasma pneumoniae (5%) (Hadden et al, 2001;
Schwerer, 2002).
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Other associations are with vaccination, pregnancy, malignancy tumors (especially
Hodgkin’s and non-Hodgkin’s lymphomas) trauma and surgery. In the last few years,
research studies have shed new light on a number of disease aspects that have enhanced
understanding of GBS. The most common type of GBS is acute inflammatory
demyelinating polyradiculoneuropathy (AIDP), the term is often used synonymously with
GBS, it’s caused by an auto-immune response directed against Schwann cell membranes.
Other axonal subtypes include: acute motor axonal neuropathy (AMAN) or Chinese
Paralytic Syndrome, attacks motor nodes of Ranvier, it is likely due to an auto-immune
response directed against the axoplasm of peripheral nerves (Asbury & McKhann, 1997).
Acute motor and sensory axonal neuropathy (AMSAN) similar to AMAN but also affects
sensory nerves with severe axonal damage. Variants of GBS include: Miller Fisher
syndrome (MFS) rare variant of GBS that manifests as a descending paralysis, proceeding
in the reverse order of the more common form of GBS, it usually affects the eye muscles
first and presents with the triad of ophthalmoplegia, ataxia, and areflexia. Acute pan-
dysautonomia most rare variant of GBS is the most rare variant of GBS, sometimes
accompanied by encephalopathy. The last one is the Bickerstaf’s brainstem encephalitis 
(BBE) a further form of GBS characterized by acute onset of ophthalmoplegia, ataxia,
disturbance of consciousness, hypereflexia or Babinski’s signs (Bickerstaf, 1957; Al-Din
et al., 1982). In the 60% to 70% of cases of the GBS the disease are associated with the
presence of IgG autoantibodies against gangliosides, these are glycosphigolipides,
components of the nerves highly expressed in central and peripheral nervous system
(Kusunokis et al., 2000; Ariga et al., 2001;Yuki, et al., 2001). Molecular mimicry of the
infectious agent and neural ganglioside antigens are thought to result in increasing of
antigangliosides blood antibodies and in the cross-reactive humoral and cytotoxic immune
responses, leading to neural damage in these patients (Schmidt et al., 2006). Treatment of
GBS involves plasma exchange (generally at least four) or intravenous immunoglobulin,
supportive care, and careful monitoring. (Guillain-Barré Syndrome Study Group, 1985;
Huge et al., 2005, 2007).
b) Clinical presentation
Although Guillain-Barré syndrome previously had been viewed as a unitary disorder with
variations, it currently is viewed as a group of syndromes with several distinctive subtypes.
Each of the subtypes have different, more or less distinct, clinical presentation,
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electrophysiologic and pathological findings. (Tojaborg, 1998). It’s possible to divided the 
different forms in demyelinatings and axonals GBS (Huges et al., 2005).
Acute inflammatory demyelinating polyneuropathy (AIDP) or “classic” GBS
Acute inflammatory demyelinating polyneuropathy (AIDP) is an autoimmune process that
is characterized by progressive weakness, mild sensory changes and autonomic
dysfunction. It is a rare disorder, afflicting about 1 person in 100,000. The usual
presentation of acute inflammatory polyradiculoneuropathy (AIDP) is subacute muscular
weakness with, areflexia, ataxia and asthenia. The signs arising from the feet before and
ascending and involving gradually in all 4 limbs in more than 60-90% cases. Weakness
plateaux at 2 weeks after onset in 50% of patients and by 4 weeks in over 90%. It is
usually symmetric, although mild asymmetry is not uncommon early in the disease course.
(Lichtenfeld, 1971; Cerisola-Cardoso et al., 2007). The cranial nerve can be also
compromise in 50% of patients have some facial weakness, although only 5% have
varying degrees of ophthalmoplegia. Autonomic dysfunction occurs not uncommonly and
is expressed in several ways include: transient hypertension or, less often, hypotension,
sinus tachycardia (cardio-sympathetic hyperactivity), bradycardia, urinary retention
achalasia and costipation who usually improves in parallel with motor and sensory
function, excessive or reduced sudomotor function and preserved skin vasomotor function
(Asahina et al., 2002; Cuciureanu and Prodan, 2004; Muller et al., 2009). Rarely, patients
show sympathetic and parasyrnpathetic overactivity simultaneously. (Lichtenfeld, 1971;
Goulon et al., 1975; Tuck et al., 1978). Oropharyngeal or respiratory weakness is a
presenting symptom in 40% of patients. Improvement in strength usually begins 1-4 weeks
after the plateau. About one third of patients require mechanical ventilation because of
respiratory failure and can cause the death in 5% of the patients (Cuciureanu and Prodan,
2004). The pain is severe in about 15% of patients, mild lower back and/or hip pain is very
common and occasionally precedes the onset of weakness (Van Doorn et al., 2008; Muller
et al., 2009).
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Also known as chronic GBS, Chronic Idiopathic Polyneuritis, or Chronic Relapsing
(Dysimmune) Polyneuropathy. Patients with CIDP have a more slowly progressive
weakness (over months or years) and a protracted course either monophasic or relapsing,
and relapses are much more common with CIDP. While a history of viral infection is often
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obtained with Guillain-Barré syndrome, this is rather uncommon in CIDP. The clinical signs
are the same of AIDP (classical form of GBS) but the occurrence of respiratory failure is
very uncommon (8-15%) with CIDP (Amato et al., 1995). Both conditions are associated
with areflexia, typical CSF findings of increased protein, abnormal nerve conduction
studies (patchy conduction slowing with Guillain-Barré syndrome and diffuse slowing with
CIDP) (Coller et al., 2005). While prednisone therapy on its own has no proven role in
Guillain-Barré syndrome, CIDP patients are sensitive to prednisone therapy (Austin, 1958).
Recurrent Guillain-Barré syndrome (RGBS)
Recurrent Guillain-Baré syndrome is a very rare entity, it’s belong with CIDP to the 
chronic demyelinating forms. The clinical presentation are similar to AIDP, the relapses are
much more frequent and numerous (more than 32) but shorter compared with CIDP. There
seems to be a tendency to accumulate neurological deficits with increasing frequency of
attacks of GB syndrome (Das et al., 2004).
Acute Motor Axonal Neuropathy (AMAN)
Although genetic predisposition has not been fully established, the AMAN type of the
disease occurs more commonly in Japan and China than in North America or Europe (Yu
et al., 2006). Many cases have been reported in rural areas of China. A particularly severe
form, attacks the motor nerves primarily (nodes of Ranvier), causing rapid progressive
weakness, flaccid symmetric paralysis with areflexia, loss of deep tendon reflexes often
with respiratory failure (Visser et al., 1995). Other typical predominant motor manifestation,
are recognized, i.e. a cranial nerve variant with ophthalmoplegia, ataxia and areflexia
(Trojaborg, 1998). Electromyographic studies and nerve conduction studies show normal
motor conduction velocity and latency with decreased amplitude of compound muscle
action potentials. F-waves and sensory nerve action potentials are often normal in this
illness (Biller, 2002). The patients with AMAN did not have sensory loss during a follow-up
period of 6 months (Visser et al., 1995). AMAN is not generally associated with marked
autonomic dysfunction except for the sudomotor hypofunction seen in patients with severe
neurological deficits (Asahina et al., 2002).
Acute Motor Sensory Axonal Neuropathy (AMSAN)
Acute motor sensory axonal neuropathy (AMSAN) is similar to AMAN but also affects
sensory nerves with severe axonal damage. Like AMAN, it is likely due to an auto-immune
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response directed against the axoplasm of peripheral nerves. Recovery is slow and often
incomplete (Griffin et al., 1995).
Miller Fisher syndrome (MFS)
Also known as Miller Fish syndrome, Miller's syndrome and Acute Disseminated
Encephalo-myeloradiculopathy. A very rare form of GBS that affects about 1-5% of GBS
patients in Europe and America, 19% Asia (Mori et al., 2001). Miller Fisher syndrome
occurs in more men than women by a ratio of approximately 2:1(Berlit et al., 1992). Unlike
GBS, MFS causes descending paralysis, i.e. paralysis that begins in the upper body and
gradually spreads downward. A spinal tap reveals the presence of elevated protein levels.
The clinical symptoms relate to dysfunction of the third, fourth, and sixth cranial nerves,
similar to ocular myasthenia (Winer, 2001). The patient experiences the classical triad of
ataxia, opthalmoplegia (bilateral hypometric saccades, bilateral saccadic pursuits) and
areflexia: loss of tendon reflexes and coordination, difficulty walking and standing, vision
problems (Mori et al., 2001). Also tingling, numbness, dizziness, nausea. The patient
experiences blurred or double vision. Damage to cranial nerves weakens the eye-muscles,
causing the double-vision. It also weakens the facial muscles, causing facial sagging and
sometimes making speech unintelligible.
Acute pandysautotomia
Similarity between acute pandysautonomia and the autonomic failure of severe Guillain-
Barre syndrome suggests that acute pandysautonomia may be an uncommon variant of
Guillain-Barre syndrome. Acute pandysautonomia was first described by Young et al. in
1969. Since this time, 27 cases have been reported. The disorder presents with clinical
features reminiscent of the autonomic failure of severe Guillain-Barre syndrome, including
severe orthostasis, impairment of gastrointestinal motility and bladder function, impotence,
impairment of pupillary reactivity and accommodation, and dryness of the eyes,
nasopharynx, and skin and photophobia (Suarez et al., 1994). Recovery occurs slowly and
is often incomplete. Commonly, patients are left with disabling residual symptoms (Mericle
and Triggs, 1997). It is associated with a high mortality rate, due to cardiovascular
involvement, and associated dysrhythmias.
c) Ethiology
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Although Guillain, Barré, and Strohl did not comment on the association of this illness with
infection, extensive clinical observations supported by epidemiological studies suggest that
about 75% of patients have a history of preceding symptoms of infection 1-3 weeks prior to
show nervous signs. The onset of neuropathic symptoms being preceded by respiratory
infection in 30–45% of cases and by gastrointestinal infection in 15–20% (Winer, 1988; Yu
et al., 2006). Serological studies reveal evidence of antecedent bacterial and viral infection
in about 30% to 50% of cases (Hughes, 1990; Mishu et al., 1993; Jacobs et al.,1998) (Fig.
4). These data are supported by accounts of outbreaks of Guillain Barré syndrome and an
association between clinical cases of food poisoning and Guillain Barré syndrome within
communities. Case controlled studies confirm a significant association with C jejuni,
Cytomegalovirus, and probably Epstein-Barr virus (Winer, 1988; Rees et al., 1995;
Kuwabara, 2004). Numerous anecdotal reports of associations with other infections exist
in the literature Herpes Simplex Virus and others viral agents were described (Dowling et
al., 1981; Winer, 1988;). Same thing happened in the bacterial antigens where Escherichia
coli, Helicobacter pylori, Campylobacter fetus, Haemophilus influenzae, and
Chlamydophila pneumoniae were also correlated with GBS (Haidl et al., 1992; Chiba et al.,
1998; Mori et al., 2000; Kono et al., 2007) (Tab.1). Even if the chemical structures of the
infectious agents contributes to the GBS genetic susceptibility of patients to infectious
agents may also contribute in clinical outcomes of the patients (Yu et al., 2006). Some
immunizations also appear to be recognised triggers of the disease, including swine flu
and rabies (Toro et al., 1977; Langmuir et al., 1984). Cases of GBS were also observed
during the pregnancy an after a surgery procedures even if are rarely compared the other
noxae’s corelation Tab 2.
Figure 4: Correlation between GBS and viral and bacterial antigens.
1
2
3
4
5
6
1) Unknown
2) Campylobacter sp.
3) EBV
4) CMV
5) Haemophilus sp.
6) Others
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Table. 1 : Different noxae ascribed to Guillain Barrè Syndrome modificated from Novelli
and Dini, 2007.
Campilobacteriosis and Guillain Barrè Syndrome
Bacterias Campylobacter jejuni
Campilobacter fetus fetus
Helicopbacter pylori
Escherichia coli
Mycoplasma pneumoniae
Haemophilus infuenzae
Chlamidophila pneumoniae
Escherichia coli
Borrelia burdorferi
Brucella melitensis
Helycobacter pylori
Viruses Herpes simplex 1-2 (HSV 1-HSV-2)
Herpes zoster (VZV)
Epstein Barr Virus (HBV)
Citomegalovirus (CMV)
HIV-1
Parainfluenza Virus 1
Influenza Virus A
Influenza Virus B
Adenovirus
Pathologies Hodgkin’s lymphoma
Non-Hodgkin’s lymphomas
Systemic lupus erithematosus
Vaccines DT vaccine
DTaP vaccine
DTP vaccine
HbOC vaccine
PRP-D vaccine
Flu vaccines
HVA vaccine
HVB vaccine
MMR vaccine
Pneumoccocus vaccine
Meningococcus vaccine
Rabie vaccine
Oral polio vaccine
Tetanus toxoid vaccine
Rosolia
Rosolia orecchioni
Varicella
Medical/Surgery problems Pregnancy
Traumatic lesions
Surgery
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Campylobacter jejuni is a species of curved, rod-shaped, non-spore forming, Gram-
negative microaerophilic, bacteria commonly found in animal feces. It is one of the most
common causes of human gastroenteritis in the world. Food poisoning caused by
Campylobacter species can be severely debilitating but is rarely life-threatening. C. jejuni
is commonly associated with poultry and naturally colonises the digestive tract of many
bird species. Contaminated drinking water and unpasteurized milk provide an efficient
means for distribution. Contaminated food is a major source of isolated infections, with
incorrectly prepared meat and poultry normally the source of the bacteria. Infection with C.
jejuni usually results in enteritis, which is characterised by abdominal pain, diarrhea, fever,
and malaise. The symptoms usually persist for between 24 hours and a week, but may be
longer. Diarrhea can vary in severity from loose stools to bloody stools. (Ryan, 2004).
Campylobacter jejuni enteritis is the most frequently identified infection preceding the
Guillain-Barré syndrome (GBS) and neural damage is thought to be induced through
molecular mimicry between C. jejuni lipo-oligosaccharide (LOS) and human gangliosides (
(Dzieciatkowska et al., 2007) (Fig. 5). The reported frequency of previous C. jejuni
infections in GBS patients varies substantially (13 to 66%). The association of C. jejuni
with GBS seems to vary in different geographic regions. In northern China, the association
reaches 66%, whereas in Europe, it may be as low as 15% (Schmidt et al., 2006), even if
in a recent study in Germany Schmidt et al. 2006 using a highly specific enzyme-linked
immunosorbent assay based on two recombinant outer antigens encoded by C. jejuni
genes Cj0017 (P39) and Cj0113 (P18), found serological evidence of a preceding C. jejuni
infection in 80.6% cases of GBS patients. The development of GBS is likely to be a
consequence of special properties of the infecting organism, since some strains such as
Penner 0:19 and 0:41 are particularly associated with GBS but not with enteritis. Other
isolated strains are: 0:1, 0:2, 0:5, 0:10, 0:16, 0:23, 0:37, 0:44, and 0:64 (Huges et al.,
1999).
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Fig. 5: Same molecular structure beween GM1 ganglioside and Lipopolysaccharide of
Campylobacter jejuni
Cytomegalovirus and Guillain Barrè Syndrome
Cytomegalovirus, CMV, is a member of the family of human herpesviridae, and is known
as human herpesvirus 5 (HHV-5). CMV is a Betaherpesvirinae, a subfamily of
herpesviridae (Todd and Will, 2006). CMV has a double stranded linear DNA genome. It is
more the 240 kilobase pairs long making it the largest member of the herpesvirus family. It
is capable of encoding more than 200 potential protein products, but the function of most
of these proteins is presently unknown. The most rappresentative is the glicoprotein B
(gB), known to be the hightest immunogen viral protein (Todd and Will, 2006). Most
healthy people who are infected by HCMV after birth have no symptoms (Ryan and Ray,
2004). Some of them develop an infectious mononucleosis/glandular fever-like syndrome,
with prolonged fever, and a mild hepatitis. HCMV is one of the TORCH infections that lead
to congenital abnormalities. Cytomegalovirus (CMV) infections are also the most frequent
viral infections preceding Guillain-Barre syndrome associated with severe sensory loss,
cranial nerve involvement, and respiratory insuficiency. High titres of CMV’s IgM antibody 
has been implicated in 10%-15% of the patients with GBS (Winer et al., 1988; Visser et al.,
1996). Like in Campyolobacter jejuni and others viral and bacterials antigens the molecular
mimicry between byological antigens and neural host tissues could be postulated through
the synthesis of autoantibodies against myelin and gangliosides (Grygorczuk et al., 2005,
Hernandez et al., 2005). The appearance of GBS signs in cytomegalovirus infection is
correlate with the significantly decrease of viremia and with increasing high-avidity
antibodies (Steininger et al., 2007). In particular CMV express ganglioside-like epitopes
that recognize specifically anti-GM2 antibodies (Khalili et al.,1999; Ang et al., 2000).
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Epstein–Barr Virus and Guillain Barrè Syndrome
The Epstein-Barr virus (EBV), also called human herpesvirus 4 (HHV-4), is a cancer
causing virus of the herpes family, which includes herpes simplex virus 1 and 2, and is one
of the most common viruses in humans. Epstein-Barr virus occurs worldwide, it is known
to cause infectious mononucleosis, is implicated in the causation of Burkitt's lymphoma
and Nasopharyngeal carcinoma, and is suspected to have a role in the pathogenesis of
chronic fatigue syndrome. Epstein-Barr virus (EBV) infection are also associated with a
wide spectrum of clinical syndromes involving the CNS and peripheral nervous system
(PNS) included Guillain Barrè syndrome (Connely et al.,1994; Portagies at al., 2000; An et
al., 2008). There are less and contradictory dates in comparison with the others study that
analysed the correlation between GBS and above mentioned bacterial and viral antigens.
Different authors described the correlation from 2% to 29% in the GBS patients (Grose et
al., 1975).
Mycoplasmosis in Guillain Barrè Syndrome
Mycoplasma pneumoniae is a very small (0,3-0,6 m) bacterium in the class Mollicutes, this
species lacks a peptidoglycan cell wall. It causes the disease bacterial pneumonia, primary
atypical pneumonia (PAP), infections of both the upper and lower respiratory tracts. Even if
this antigen is the 4th cause of GBS in the patients, the publications about it are rare and
they associate the Mycoplasma pneumoniae with Miller Fischer syndrome (MFS), AMAN
and AIDP forms (Hsueh et al., 2004; Susuki et al., 2004). In a study Goldschimdt et al.
1980 using a counterimmunoelectrophoresis (CIEP) to determine precipitating antibodies
of Mycoplasma pneumoniae retrospectively in sera from 100 patients with Guillain-Barré
syndrome (GBS) they found specific antibodies in 5 patients with GBS, in 1 with acute
cerebellar ataxia, and in 1 with acute disseminated encephalomyelitis. The GBS forms
subsequently to Mycoplasma pneumoniae infection were often correlate, even at 12%,
with serum anti-Galactocerebroside (Gal-C) IgM antibody, caused by mycoplasma
molecular mimicry (Ang et al., 2002). In contrast Susuki et al. 2004 describe that the
presence of Anti-GalC antibodies may be an epiphenomenon in particular in AIDP form
and that in certain cases, anti-GM1 antibodies may cause acute motor axonal neuropathy.
Miscellaneous of viruses implicated in Guillain Barrè syndrome
The different forms of GBS are also described in correlation with others viral antigens.
Neuropathy occur in approximately 10% to 15% of human immunodeficiency virus
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infection and acquired immunodeficiency syndrome (Verma, 2001), the HIV can play a rule
in the appearance of different forms of GBS, normally it was described in AIDP and in
CIDP form, one case was also reported in the acute motor axonal neuropathy (Wagner
and Bromberg, 2007). The mechanisms proposed for GBS in HIV-1-infected patients
include a direct action of HIV-1 on the nerves by neurotropic strains, or of autoimmune
mechanisms, with the formation of antibodies against myelin or gangliodides secondary to
the abnormal immunoregulation determined by HIV infection (Dalakas et al., 1988). In a
case of Fisher/Guillain-Barré syndrome form the serum was positive for anti-GQ1b IgG
antibody and show a markedly decreased CD4 cell counts. This indicates that
Fisher/Guillain-Barré syndrome may occur even in severely immunosuppressed patients
and that anti-ganglioside antibody production is possibly mediated by a T cell-independent
process (Hiraga et al., 2007). This fact are confirm by Deraga et al. 2006 by the
description of an case where no perivascular and perineural lymphocyte infiltration are
detected. This appear in contradiction with the hypothesis that the in GBS induced by HIV,
in particular in the first moment of the pathogenesis, T cells may also influence the
recruitment of other cells of the immunologic response such as macrophages that react
against Schwann cells and fibroblasts, resulting in the process of demyelinization (de
Castro et al., 2006). These findings suggest that the changes mediated by antibodies are
the most important process, in agreement with the pathogenetic mechanism proposed for
the onset of GBS, which occurs after infections, as is the case for Campylobacter jejuni
infection (Wilson, 2005). Influenza Virus A and B, Parainfluenza Virus 1, Adenovirus and
Herpes Virus are also described like a possible causes in the 1% of the cases of the GBS.
In particular in the cases of the Influenza Virus 1 the viral protein NS2 can mimicry the
sequence region of the human myelin protein P2, inducing a mitoses and the subsequent
attack by specific T lymphocytes against myelin of peripheral nerves (Jacobs et al, 1998).
Miscellaneous of bacterias implicated in Guillain Barrè syndrome
Haemophilus influenzae is a Gram-negative human pathogen whose outer membrane
contains LPS. Guillain–Barré syndrome patients with H. influenzae infection were
characterized clinically as having had a preceding respiratory tract infection, less frequent
cranial and sensory nerve involvement, and good recovery (Apicella, 1994). In 67% of the
cases was diagnosticated the AMAN pattern. Strain of H. influenzae has a GM1-like
structure and elicits Guillain–Barré syndrome (Mori et al., 1999) is supported by the strong
association between the anti-H. influenzae positivity and the anti-GM1 positivity. In different
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studies the patients showed the positivity for IgG and IgM anti-ganglioside antibodies
against ganglioside GM1, GM1b, GD1a, GalNac-GD1a, GD1b or GQ1b (Mori et al., 2000).
The secretion of anti GM1 antibody were also observed in three cases of Chlamydophila
pneumoniae infections (Haidl et al., 1992; Coste et al., 2002). Kono et al. in 2007 describe
the first case of woman who developed rapidly progressive GBS, AMAN form with high
titers of IgG antibodies to GM1 and GalNAc-GD1a, 18 days after sustaining urosepsis due
to Escherichia coli. Helicobacter pylori is a common cause of gastroduodenal disorders.
Antigenic mimicry between H. pylori and the host is speculated to be a possible
mechanism for the mucosal damage. Cheba et al. 1998 have reported the presence of
several IgG antibodies against crude H. pylori antigens in the cerebrospinal fluid (CSF) of
patients with GBS. The demyelinating polyradiculoneuropathy of GBS occurred also in
some cases after disappearance of erythema migrans subsequently Borrelia burdorferi
infection (Wiszniewska et al., 2005). Watanabe et al., 2005 reported that an LPS of
Brucella melitensis had a GM1 ganglioside-like structure and that B. melitensis is a new
etiological agent for GBS. Immunization of mice with B. melitensis induced mice to show
flaccid limb weakness and ataxia-like symptoms that may be due to molecular mimicry
between B. melitensis LPS containing GM1 ganglioside-like structures and peripheral
nerve gangliosides.
Parassitosis implicated in Guillain Barrè syndrome
There are only four reports in the world that correlate (Toxoplasma gondii), endocellular
parasite, in GBS patients (Dano et al. 1985; Bossi et al., 1998). One cases o RGBS was
described in 1993 by Bahatia and Misra caused following acute filariasis (Wuchereria
bancrofti)
Pathology implicated in Guillain Barrè syndrome
Effects of lymphoma on the peripheral nervous system have been reviewed by (Hughes et
al., 1994; Vallat et al., 1995). There have been at least 10 reports of GBS in association
with Hodgkin's disease, but association with non-Hodgkin's-lymphoma is rare. Chronic
inflammatory demyelinating polyneuropathy (CIDP) in lymphoproliferative disease has
been distinguished from GBS by its subacute or chronic course but both might be
regarded as a part of a spectrum (Re et al., 2000). Systemic lupus erythematosus (SLE),
in the peripheral neuropathies are relatively uncommon and rarely present as the initial
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symptom can be consider. Like described in the others cases, anti-GM1 blood antibody is
elevated in the serum of such rheumatic disorders, as SLE (Zeballos et al., 1994).
Vaccines
In the United State during 1976-77 was the first observation of an increase of GBS cases
in the population after the administration of swine influenza vaccine. The signs appears
inside the 5 weeks after the vaccination in 1 case every administrated 100000 doses
(Schonberger et al., 1979). Studies of influenza vaccines used in subsequent years,
however, have found small or no increased risk of GBS, 5-18 cases every 10 millions of
administrated doses. Older formulations of rabies vaccine cultured in mammalian brain
tissues have been found to have an increased risk of GBS, but newer formulations of
rabies vaccine, derived from chick embryo cells, do not appear to be associated with GBS
at a greater than expected rate. In an earlier review, the Institute of Medicine concluded
that the evidence favoured a causal association between oral polio vaccine and tetanus
toxoid-containing vaccines and GBS. However, recent evidence from large epidemiological
studies and mass immunization campaigns in different countries found no correlation
between oral polio vaccine or tetanus toxoid-containing vaccines and GBS. Spontaneous
reports to the US Vaccine Adverse Events Reporting System shortly after the introduction
of quadrivalent conjugated meningococcal vaccine (MCV4) raised concerns of a possible
association with GBS (Haber et al., 2009). Others correlations was describe between A-B
hepatitis and the GBS, the development of nervous system signs occurs 10 weeks after
immunization with recombinant hepatitis B vaccine (Khamaisi et al., 2004) . Comparisons
with expected rates of GBS, however, were inconclusive for an increased risk, and lack of
controlled epidemiological studies makes it difficult to draw conclusions about a causal
association (Tab 1).
Medical and surgical problems
Various types of trauma, including intracranial and peripheral lesions and in general
surgical procedures, orthopaedic operations, and spinal anaesthesia can be the causes of
the onset of GBS (Duncan and Kennedy, 1997, de Freiatas et al., 2006). Inexplicable
diffuse peripheral neuropathy in the postoperative period is a diagnostic conundrum in
which Guillain-Barré syndrome must be considered. Guillain-Barré syndrome is an unusual
postoperative complication that usually has onset in the lower extremities (Bamberg and
Thys, 2005). AIDP was also reported during all the three trimesters of pregnancy and in
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the post-partum period. It is known to worsen during the post-partum period due to a rapid
increase in delayed type hypersensitivity during this period. Relapse during successive
pregnancies has been reported (Goyal et al., 2004). Though the incidence of AIDP in
pregnancy (every 100000) is similar to that in the normal population: 0.89 for pregnant
women, 1.37 for women during the first 90 days, and 2.93 during the first 30 days after
delivery, in particularly during the first 2 weeks postpartum, only 50 cases of AIDP during
pregnancy have been reported. (Cheng et al., 1998; Goyal et al., 2004)
d) Pathogenesis
Guillain Barré syndrome remains one of the most fascinating yet challenging conditions
despite considerable advances in its understanding and treatment over the past 10 years.
The studies of Asbury and colleagues 1969, suggested that the earliest hall mark of
Guillain Barré syndrome was the presence of perifascicular lymphocytic cuffs of small
vessels in the endoneurium and perineurium. This appears to be associated with
demyelination, which is typically macrophage associated (Prineas, 1981). The evidence
from histological examination of peripheral nerve biopsy and postmortem samples
suggests that both cell mediated and humoral mechanisms are involved in the
pathogenesis (Huge, 2001). Pathological studies of patients with the AMAN and in AMSAN
forms, where the prevalence trigger is the axons, the alterations are caused by the multiple
action of antibodies, complement and mostly by the macrophages that through the
periaxonal space of the internode damaged the axolemma without altered the myelin. In
contrast in AIDP and CIDP the studies reveal that even if the signs of primary injury to
myelin sheath and Schwann cells of sensory and motor nerves are targeted by the auto-
antibodies (humoral response), the most significant damages are caused by the presence
of T lymphocytes and monocyes (cells response). In these lasts two case when the
alteration are heavy and elderly the axolemma can be altered by the same mechanism of
AMAN and AMSAN (Winer, 2001, Willson and Yuki, 2002). Much of the research into GBS
over the last decade has focused on the forms mediated by autoantibodies against the
different components of the myelin, in particular antiganglioside antibodies (Ariga et al.,
2001, 2005; Wilson, 2005) (Tab.2)
Table 2: Components of nervous myelin (Novelli and Dini, 2007).
Substances Component Percentageof components
PROTEINS (20-25%) P0 (protein 0) 50%
MBP (myelin basic protein) 18%
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PMP22 (peripheral myelin protein 22) 5-10%
P2 1-5%
CNP 0,4%
MAG 0,1%
MOG 0,01%
PLP 0,001%
LIPIDS (78-80%)
Cholesterol (35-40%)
Glicosphingolipides (17-19%)
Gangliosides (more rappresentative) LM1
GM1 15% motor fibres
5% sensitive fibres
GM2
GD1a
GalNAc-GD1
GD1b
GD2
GD3
GM3
GQ1b
GT1b
GA1
Cerebrosides Galactocerebrosides
GalC,sGalC, GalDG
Solfatide (Gals)
SGPG,SGLPG
Phospholipids (45-46%) sphingomyelin 15%
phosphatidatelonamine 13-14%
Phosphatidilserine 7-8%
Phosphatidilcoline 6-7%
Phosphatidilethanolamine 2-3%
The discovery of antiganglioside and others antibodies in the serum of patients with
Guillain Barré syndrome has sparked of an enormous proliferation of publications. The
frequency of such antibodies varies from as low as 29% up to nearly 70% (Gregorson et
al. 1993, Kusunoki, 1999) although the average figure is probably around 30%. Another
possible antibody that might be relevant is some of these patients is antibody directed
towards the myelin protein PMP 22, MBP, P0, P2 particularly in AIDP and in CIDP (Gabriel
et al., 2000; Quarles, 2002; Csurhes et al., 2005), galactocerebrosides (GalC) (Ang et al.
2002), sulfatide (Obara et al. 2003). The different forms of the GBS presented various
affinity with the gangliosides and the others antigens (Tab 3).
Table. 3: Association between different gangliosides and protein component of myelin with
Guillaine Barrè syndrome forms and antibodies secretion.
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Host antigens Antibodies GBS forms
LM1 IgG AIDP
GM1 IgG AMAN
GM1b IgG AMAN
GD1a IgA, IgM, IgG, AMAN
GalNAc-GD1a IgG AMAN
GalNAc-GD1a+GM2 IgM CIDP
GD1b IgG AMSAN
GD3 IgG MFS
GM2 IgM AIDP
GQ1b+GT1a IgG MFS
GalC IgM, IgG AMAN
MAG IgM CIDP
P0, P2, PMB22, MBP IgM, IgG AIDP, CIDP
SGPG IgM AMSAM
SGPG (SGLPG)+MAG IgM CIDP
These antibodies providing a possible auto immune mechanism for the disease. This
"mistaken immune attack" may arise because the surface of C. jejuni and others antigens
contains polysaccharides (Lipopolisaccharide LPS, Lipooligopolisacharide LOS) that
resemble glycoconjugates of the human nerve tissues (Fig. 5) (Tab.4). This resemblance
has been termed "molecular mimicry," which is defined as the dual recognition, by a single
B- or T-cell receptor, of a microbe's structure and an antigen of the host (gangliosides,
cerebroside, myelin protein), and is the mechanism by which infections trigger cross-
reactive antibodies or T cells that can lead to autoimmune diseases (Yuki, 1997; Ang et al.,
2004).
Table. 4: Association between different gangliosides and protein component of myelin with
different viral and bacterial antigensin Guillaine Barrè.
Antigens Gangliosides Structure Non Ganglioside structure
Campylobacter jejuni GM1, GM1b, GM3, GD1a, GD1b GalNac-GD1a, GD2, GD3 ,GT1a, GQ1b,
asialo GM1 like (GA1),
SGBG (L2/HNK-1),
Citomegalovirus GM2 SGBG (L2/HNK-1),
MAG/SGPG
Haemophilus
influenzae
GM1, GT1a, GQ1b
Mycoplasma
pneumoniae
GA1
Brucella melitensis GM1
Escherichia coli asialo GM1 like (GA1)
Helycobacter pylori P0, P2, PMP22, MBP
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However, T cells are also likely to play a role in GBS. T cell help is an important
prerequisite for B cell maturation and antibody production. T cells are found in the
peripheral nerves of some subjects with GBS (Pollard et al., 1986, 1987; Honavard et al.
1991). Increased numbers of circulating activated T cells in patients with GBS altered
proportions of T cell subsets, (Dahle et al., 1994) raised circulating levels of IL-2 and
soluble IL-2 receptor, (Bamsil et al., 1991; Hartung et al., 1991) and oligoclonal expansion
of T cells bearing particular T cell receptor V and V genes (Koda et al., 2003) all support a
role for T cells in GBS and CIDP. Furthermore, experimental autoimmune neuritis (EAN),
an animal model of GBS, which can be induced by inoculation of susceptible animals with
myelin proteins, or peptides from P2,30 P0,31–34 or PMP-22 can also be passively
transferred by activated T cells specific for peripheral myelin antigens. The spectrum of
cytokines produced by T cells has a strong influence on the outcome of immune
responses. Human CD4+ helper T cells can be divided into two categories. The first one,
Th1 cells, produce the cytokines IL-2, IFN-, tumour necrosis factor TNF-, and TNF-.
Th1 responses promote cell mediated inflammatory immune responses by the proliferation
of B-T activated lymphocytes, the secretion of antibodies by plasmacells, the proliferation
and the improvement of citotoxic activity of NK and citotoxic T lymphocytes, all important
factors for development of many organ specific autoimmune diseases. The second one,
Th2 type T cells, produce IL-4, IL-5, IL-10, and IL-13, and are thought to suppress
inflammation and help eosinophils and B cell antibody production, and may play beneficial
roles in human organ specific inflammatory diseases. Th1 responses have been shown to
be important in EAN-GBS induction, whereas the recovery phase is associated with a
switch to Th2 (Csurhes et al., 2005).
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iii) Autoimmune disease in birds
a)Introduction
The immune system has developed many effective ways to protect an individual from
environmental insults and disease. Adaptive (specific) immunity will focus these defensive
efforts very specifically on a given antigen in order to remove and/or destroy that antigen.
However, when this specific response is directed against self-antigen, the result is
autoimmune disease. Autoimmune disease is defined as a disease caused by a
breakdown of self-tolerance such that the adaptive immune system responds to a self
(autologous)-antigen and causes cell and tissue damage. Autoimmune diseases can be
categorized into two basic types: organ-specific and systemic diseases. In organ-specific
or localized autoimmune diseases, immune recognition is cell-/ tissue-specific as is the
resulting immunopathology. Examples of organ-specific autoimmune diseases include
Hashimoto’s thyroiditis, type-1 diabetes, vitiligo and many others. In systemic autoimmune
disease, such as systemic lupus erythematosus (SLE), multiple organs are affected. Self-
tolerance is an essential property of the immune system designed to ensure that
individuals do not respond to their own antigens. Tolerance to self-antigens is normally
maintained by selective processes that prevent the maturation of self-antigen-specific
lymphocytes and that inactivate or delete self-reactive lymphocytes that do mature and
enter the periphery. Loss of self-tolerance may result from abnormal selection or regulation
of self-reactive lymphocytes and by abnormalities in the way that self-antigens are
processed and presented to the immune system.Self-tolerance is primarily inherent in the
T cell compartment. This is due in part to the rigorous selection processes T cells
encounter during maturation in the thymus, the important regulatory function of T cells in
adaptive immune responses and the restriction of T cells to recognition of antigenic-
peptides in association with self major histocompatibility complex (MHC).
Failures of self-tolerance within the T cell compartment can result in autoimmune diseases
in which the autoimmune lesion is caused by cell-mediated and/or humoral immune
responses. Autoimmune diseases typically are multifactorial in nature, requiring several
components such as genetic susceptibility, immunological influences and environmental
factors for expression. Unfortunately, the relative contribution of these factors to the
development of autoimmune disease is not clear cut and cannot be easily dissected. In
organ-specific autoimmune diseases, genetic susceptibility is frequently associated with an
inherent target cell defect that predisposes it to immunorecognition and may include
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aberrant immunological activity at various levels (e.g. dendritic cells/macrophages, B cells
and T cells). The autoimmune destruction of cells has been found to be associated with a
lack of regulatory function within the immune system, heightened immune activity and
altered responsiveness of immune components to factors from other physiological
systems. The role of environmental factors in the development of autoimmune disease is
also multifaceted and may include infections by microbes as well as exposure to
chemicals. The consequences of having adaptive immune mechanisms specifically
focused on a selfantigen are clearly destructive. It is puzzling, however, that autoimmune
attacks against components such as the myelin sheath in multiple sclerosis, pigment cells
in vitiligo and thyroid cells in autoimmune thyroiditis, do not necessarily destroy all of these
target cells as would be implied by the specificity of the recognition. Rather, cell/tissue
destruction tends to be progressive in nature, suggesting an important interplay between
the target tissue and the antigens it displays, immune recognition and immunoregulation.
Understanding these interrelationships will be important in the prevention and treatment of
autoimmune disease.
b) Autoimmune diseases of poultry
Autoimmune diseases have rarely been reported in birds. This may be a result of our
inability to recognize autoimmune disease rather than a resistance to autoimmune
problems (Harrison, 1984). The specie most studied for the autoimmune disease is the
poultry. These pathologies are studied by avian and humane medicine researchers, over
the years, the chicken has made significant contributions to the understanding of the
components and mechanisms involved in autoimmune diseases, primarily because some
lines of chickens spontaneously, and predictably, develop autoimmune disease. For
example, the Smyth line (SL) chicken is the only animal model for the pigmentation
disorder vitiligo, that manifests all the clinical and biological symptoms of the human
disease. The obese strain (OS) chicken is one of the most-valued and best models for
spontaneously occurring Hashimoto thyroiditis and the University of California at Davis
(UCD) 200/206 chicken lines are the only model for spontaneously occurring scleroderma
that presents the combination of symptoms observed in humans. Autoimmune disease
does not appear to be of widespread concern in poultry production. Although, poultry
breeding programmes have selected against inherited diseases, susceptibility to
autoimmune diseases may be selected for in the absence of disease expression.
Considering the frequently observed disorders associated with high intensity poultry
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production, such as leg, endocrine and nervous system problems, as well as metabolic,
integumental, pulmonary, alimentary and reproductive tract problems, one may ask
whether or not there is an underlying autoimmune component to these disorders. Given
the multifactorial nature of autoimmune disease, the danger lies in the combination of
factors encountered by a susceptible population that will lead to the expression of the
disease. Hence, poultry breeding programmes will need to include attention to the role of
the immune system in health and disease. The study of autoimmune disease in
susceptible lines of chickens has been a driving force for the development of assay
systems, probes and tools to study fundamental aspects of immune function,
immunopathology and immunophysiology in poultry. Moreover, the SL, OS and UCD-
200/206 lines are excellent models to study the cause–effect relationship between a
genetically controlled disease, immune function and environmental factors, and have been
an incentive for the mapping of susceptibility genes and studies on the mechanistic links
between susceptibility genes and failure of self-tolerance. Even if the most common and
studied disease are rappresented by vitiligo, thyroiditis, scleroderma, reports on other
occurrences of, and investigations into, autoimmune disease in poultry can be found in the
literature. Included are experimental viral arthritis, experimental allergic encephalomyelitis
and ovarian autoimmune disease (Blaszczyk et al., 1978; Pertile et al.,1996; Barua and
Yoshimura, 2001).
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Experimantal Studies
i) Introduction
How is possible to understand reading the introduction parts that explain the proventricular
dilatation disease, even if it’s studied for more than 30 years, many diferent aspects of it 
appear still unclear. In particular this is really true for what concern the epidemiology,
aetiology, and the pathogenesis of this disease.
This is caused by many difficult aspects that the researcher meet during their studies: the
few numbers of PDD affected birds that is possible to analysed in the same time also in
very big breeding centres, the difficult to reproduce experimentally the disease, the rapidity
of the development of the pathology in the grater part of the cases and the difficult to
diagnose it before the birds died.
Because the high mortality rate of affected birds, until the beginning the researcher
focalized their studies to discover the exactly aetiological agent to reduce the risk of the
dissemination of the PDD. Different biological antigens were investigated, more than six
different viruses were suppose associated with the disease in the last twenty years, Avian
Bornavirus the last one. Unfortunately none have reproduce experimentally the disease
using an isolated virus from afected bird satisfying the Koch’s postulates, so until now the 
really aetiological antigen remain unclear.
Analysing this aspect and the clinical presentation of this disease we found various
analogies with the human Guillain Barrè syndrome, so we have focalised the our study to
clarify the pathogenesis. To do this, we investigated if the PDD can be an autoimmune
disease and if a possible presence of the blood antiganglioside antibodies can be the
starter of this autoimmune pathological mechanism, like was observed in more than 50%
of the GBS’s cases. This aspect also to understand more the pathogenesis of this disease, 
can be apply to help the breeders and the veterinaries to diagnose this still unclear.
ii) Matherials and Methods.
During the last three years (2007-2010) we have collected 200 crop biopsy tissues
samples of afected and healthy birds, diferent organs samples of 10 PDD’s suppose 
death parrots, 1140 plasma samples, obtained from 14 different psittacine bird generas of
italian, spanish, portuguese and brasilian breeding centers. Furthermore for the great part
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of the animal we collected the datas rappresented by: age, sex, signs of disease. All these
samples was analysed in the University of Camerino, Faculty of Veterinary Medicine.
The different crops and organs samples was utilised for different analyses: to the
diagnosis and of the possible PDD’s afected birds (golden standard method) and to 
observed the most significant alteration of crops and organs that occur during the disease.
The plasma samples was analysed to put in evidence the possible presence and the
corelation between the antiganglioside antibodies and the pathological PDD’s status of 
the parrots diagnosticated ante mortem by the evaluation of the eventually perigangliar
infiltration of the nervous crop structures.
The first steps of our study, using HE staining for the morphological examination, luxol fast
blue (LFB) for the myelin status, Dane & Hermann’s tetrachromic stain (DHTS) for
characterization of the mucins and for different epithelial layers of the crop and the IHC for
the evaluation of the mitotic activity, was focalized to described the morphological
mycroscopically aspects of the lesions observed in the crop tissues of affected birds
comparing with healthy subject. Totally we analysed 60 crop biopsy obtained from
unaffected and from symptomatic and asymptomatic affected parrots.
Subsequently, using the IHC, we have immunophenotypized the lymphoplasmacytic
perigangliar infiltrate of the PDD positive crops, to understand if it presented the typical
aspects of the infiltration observed during an immunomediated process.
At the end we used the serological methods, E.L.I.S.A., to check in the 1140 blood sample
the eventually presence of antigangioside antibodies direct to: the specific GM1, GT1b
gangliosides, two of the most representative glicosfingolipides of the nervous system, and
to all different gangliosides of the bird myelin. To do this we used like antigens the
commercial bovine GM1 e GT1b (SIGMA), while for the last analysis we extract the
antigens (gangliosides pool) directly from CNS and PNS of the parrots in our laboratory.
Furthermore we compare in 140 cases the histological aspect of the crop biopsy (which
represent the in vivo  “golden standard” diagnostic method), with the serological data. In 
102 of these, we also obtained the clinical presentation of the patient during the period of 1
year and the radiological aspect in L/L and V/D position. This last comparative study that
analized the different serological, histological, symptomatological and radiological
presentations obtained from the same subjects, it was very important to evidence a
possible alternative use of the blood antigangliosides evaluation for the diagnostic and non
invasive method for this disease.
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In February 2008 to further investigate in vivo the role of anti-ganglioside autoimmunity in
the pathogenesis of the disease, we challenged 6 cockatiels (Nymphicus hollandicus)
intraperitoneally and orally with a 1 mg of purified gangliosides diluted in 1 ml of 0,9%
NaCl solution with adjuvant added, and two control cockatiels by same route only with
NaCl solution.
Morphological staining
Tissue samples were collected from each birds and fixed in 10% neutral buffered formalin
for a minimum of 12h, embedded in paraffin, sectioned in 3µm thick sections, and stained.
Haematoxylin Eosin Staining
Bring sections to distilled water, stain nuclei with the alum haematoxylin (Carazzi) for 10
minutes, rinse in running tap water for three time, the last one for 15 minutes. Stain the
slide with eosin for 1 minutes and wash rapidly, 2 seconds, three time. Dehydrate with
decrease concentration of alcohol baths, put the section in two xilolo’s baths, and mount
by resin (Permount, Histoline,Milan, Italy).
Luxol fast blue (LFB)
Deparaffinize and hydrate to 95% alcohol, the section and put it in Luxol fast blue solution
overnight at 60°C. Rinse in 95% alcohol and wash by distilled water. Put the slide in lithium
carbonate solution for 5 seconds and then in 70% alcohol, two changes, 10 seconds each.
Wash in distilled water. Rinse slide in 70% alcohol end color with eosin for 1 minute. Rinse
in distilled water and stain by cresyl violet for 1 minute, wash again by distilled water and
dehydrate with decrease concentration of alcohol baths, put the section in two xilolo’s 
baths, and mount by resin (Permount, Histoline,Milan, Italy).
Dane & Hermann’s tetrachromic stain (DHTS)
Deparaffinize and hydrate to 95% alcohol, the section and put it in Meyer’s emalume for 
10 minutes, wash with distilled water. Color the section by a 1% floxina B water solution for
3 minutes, wash for 1 minute with water as soon the discoloration of section and rinse by
distilled water. Color by a solution 1:1 of 1% alcian blu and 1% acetic acid. Wash for 1
minute with water and rinse by distilled water. Colour for 13 minutes the section by a 0,5%
orange G solution in 2% phosphotungstic acid solution in distilled water. Immerse 10 times
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in 95% ethanol. Immerse 35 times in 100% ethanol. Clarify by renew xylene many time
and mount by resin (Permount, Histoline,Milan, Italy).
Immunohistochemical stain
To evaluate the mitotic activity of cels constituting the epithelial basal layer of the crop’s 
mucosa, and to characterized the fenotype of cell-mediated infiltrates, an
immunohistochemical test was employed. In particular to asses the mitotic index, we used
a rabbit polyclonal antibody (pAb) specific to PCNA antigen (Novocastra, London), diluted
1:100 in TBS+1% BSA.
Periganglia lymphoplasmacytic infiltrate was immunohistochemically phenotipized by a
panel of antibodies constituted by a monoclonal rat-anti CD3 antibody (mAb)
(Serotec,USA ) diluted 1:200 in TBS+1%BSA, mouse-anti CD8 mAb (Southern
Biotechnology Associates Eching, Germany) diluted 1:200 in the same buffer, and mouse-
anti lysozime mAb (Novocastra, London) diluted 1:500. For histochemical and
immunohistochemical tests, sections were placed on pretreated slides (Bio-Optica, Milan,
Italy) to promote adhesion and dried overnight at 37°C. After being dewaxed, sections
were placed in EDTA buffer, pH 9.0, and processed in a microwave oven at 650 W for two
cycles of 10 min each to enhance their antigenicity. Slides were then allowed to cool at
room temperature for at least 20 min before being further processed for immunostaining
employing standard procedures. Tissue sections were incubated overnight in a moist
chamber at 4°C with different primary antibodies, diluted in Tris-buffered solution (TBS)
containing 0.1% crystalline bovine serum albumin (BSA). Binding of the previously
mentioned antibodies was detected with ABC-peroxydase (Vector Laboratories Inc.,
Burlingame, CA) techniques using 1:200 diluted biotin conjugated goat anti-rabbit
immunoglobulin G (Vector Laboratories Inc., Burlingame, CA) and a 1:200 diluted
biotinylated goat anti-mouse immunoglobulin (AO433; DAKO, Glostrup, Denmark), applied
for 45 min at room temperature as secondary antibodies. The enzymatic reaction was
developed with 3,1-diaminobenzydine (DAB) (Sigma, St. Louis, MO) as substrate for ABC-
peroxydase technique, by using Meyer hematoxylin as nuclear counter stain. Vector Vip
and Vector Blue (Vector Laboratories Inc., Burlingame, CA) were used as second and third
chromogen in IHC triple stains tests. Specific primary antibodies substituted with TBS or
non-immune sera were used as negative controls in immunohistochemical techniques.
Histological examination of crop’s samples included assessment of thickness of epithelial 
layer, the rate of PCNA expression by cells of the basal layer of mucosal epithelium and
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the phenotype characterization of the mononuclear cells that constituting the periganglia
infiltrate. For immunohistochemical evaluation, ten 40x randomly selected fields were
analysed for each sample and the number of positive cells/field was recorded. The value
of expression of PCNA per sample was expressed as the mean value obtained from all ten
values.
Ganglioside extraction
Gangliosides were extracted from brain, spinal cord, sciatic nerves during the
necroscopical examination of PDD non affected parrots. Tissue was cut with a freezing
microtome into approximately 40 coronal sections throughout the sample. The tissue slices
for each area were collected and homogenized for 10 min at 48C in acetone and
incubated at 20°C for 15 min. After centrifugation, the supernatant was discarded and 4 ml
of cold acetone was added. This procedure was repeated twice. The pellet was re-
extracted (three times) with 3.3 ml of chloroform-methanol-distilled water (1 : 2 : 0.3 v/v/v)
and incubated for 15 min at 378C in a water bath. The ratio of chloroform-methanol-
distilled water was adjusted to 1 : 1 : 1 v/v/v. This solution was shaken overnight and
gangliosides were then separated from other lipids by partitioning into the aqueous
methanol (upper) phase. The lower phase was removed with a syringe and discarded. The
membrane between both phases was saved together with the remaining upper phase and
dried under air in a 37°C water bath and then used for antiganglioside antibodies blood
analysis (Fig. 14).
Serological evaluation of antiganglioside antibodies (PATENTED PROCEDURE).
1 g of antigens, bovine Gm1 ganglioside C73H131N3O31 (SIGMA) or bovine GT1b
ganglioside Gt1b bovino (SIGMA), C95H195N5O49 (SIGMA), or extracted pool of parrot
gangliosides, was adsorbe overnight (12 h) on ELISA plate (Nunc) at 4°C in 100 ml of PBS
pH 7,2 (phosphate buffer saline). Rinse 3 times with 200 l of PBST 0,01% (phosphate
buffer saline + tween 20). Fixing of the antigens on the plate by 200 l of BSA 1% (bovine
serum albumine+PBS) then wash again 3 times with 200 of PBST 0,01% (phosphate
buffer saline + tween 20). Bindind and applied for 3 h at 37°C 100l of rabbit anti-bovine-
GM1 and rabbit anti-bovine-GT1b diluted 1:5000 in PBS and an hyperimmune parrot
serum diluted 1:50 in PBS for extracted pool of gangliosides in positive control wells,
100l of healthy bird plasma diluted 1:50 in PBS in negative control wells and 100l diluted
1:50 in PBS of parot’s plasma inexamination. At the end of incubation period rinse 3
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times with 200l of PBST 0,01% (phosphate bufer saline + tween 20). Subsequent apply 
for 90 minutes (continuously shaking): 100l of secondary peroxidate antibodies consisting
by polyclonal goat anti rabbit IgG diluted in 1:2500 in PBS in the GM1 and GT1b control
positive wells, while in the positive control well containing extracted gangliosides pool, in
all three negative controls wells and into the well of the serum sample in examination,
100l ofsecondary peroxidate antibody consisting by monoclonal rabbit anti chicken IgG
diluted in 1:2500 in PBS. At the end of the incubation time, rinse 3 times with 200 l of 
PBST 0,01% (phosphate buffer saline + tween 20) and apply 100 l of ABST (SIGMA) for
30 minutes, subsequently stop the peroxidase activity with 100 l of SDS 1%. After 3
minutes read by a spectrophotometer working at 405 nm. The cut-off value for each
antigen resulted from the mean of the positive and negative control O.D. values, after
subtraction of the O.D. value of a ganglioside-coated well incubated only with secondary
antibody (without primary antibody incubation). In each test, positive serum sample
(potentially indicative of positive PDD parrot) consisted in O.D. value higher than the mean
O.D. one resulting from the mean subtracted of the white O.D. value.
iii) Results
During the histological evaluation of the 60 crop samples the periganglia infiltrate of
lymphomonocytic nature was observed in 17. Of those 17, 8 (66,6%) came from the group
of the 12 symptomatic birds and 9 (18,7%) from the clinically healthy birds (Photo. 1).
Severity of chronic inflammatory infiltrate, was graded from 0 to 3, according to the
prevalence and amount of the difference inflammatory cells, score 0 , score 1 , score 2 ,
score 3; the score values are determined as reported by Martini et al. 2005.
in reported c. In the 17 affected and syntomatic birds the mean obtained was evaluated in
2.8 in contrast to the value of 0,9 obtained from healthy parrots. In the 9 asymptomatic
PDD positive animals all perigangliar infiltrates consisting in a high percentage of CD3+
lymphocytes, with a variable percentage of plasma cells and macrophages (Fig. 8). Only
occasional CD8+ cells (citotoxic T lymphocytes, CTL) and macrophages were observed
mixed with scattered CD3+ T cells. On the contrary in the 8 symptomatic positive birds a
large percentage of these CD8+ lymphocytes and macrophages were associated with
moderate to severe (score 2 to 3) periganglia mononuclear cell infiltration (Fig. 8). In these
8 samples, LFB stain also revealed a moderate to severe degree of demyelination (Fig. 9).
Differences were also observed in basal crop epithelium PCNA positive cells-count when
pathological (Fig. 12) and healthy (Fig. 13) crop specimens were compared. In particular
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the mean value of PCNA positive cells counted in affected crop samples resulted 75,8.
The value obtained in samples belonging to asymptomatic –unaffected parrots was of
186,6 PCNA positive cells more than the double value of the cells population count in the
healthy. Notably, in the cells of basal layer, PCNA cells count varied independently to the
degree of the pathology and the severity of the lymphoid infiltrate in the two groups.
Similarly, specimens stained with DHTS showed a different thickness in pre-keratinized
epithelial layer of the crop between groups, with an evident thinness of this stratum in
affected birds (Fig. 10-11).
About the 900 plasma samples obtained from asymptomatic birds we found 13,5% of birds
positive for all the three antigens. To identified the more susceptible genera for an
increasing of antiganglioside antibodies values we create 5 groups subdivide on the basis
of the morphology, behaviour and geographic origin of the parots: “Group Amazon”: 
Amazona sp., Pionus sp. Pionites sp.; “Group Macaw”:Ara sp. Cyanopsitta sp.
Anodorhynchus sp.; Aratinga sp., Cyanolisus sp., “Group Grey”: Psitthacus sp.;
Poicephalus sp., Choracopsis sp. “Group Cockatoo” Cacatua sp.,Nynphicus sp., Eolophus
sp., Calyptorinchus sp., “Group Lory”: Lori sp., Lorius sp., Eclectus sp.. The results show
the positivity rate quantificated in 23% for “Group Amazzon”; 11% for “Group Macaw”, 10% 
for “Group Greys”, 15,73% for “Group Cockatoo” and the 2% for “Group Lory” .
On the basis of the age we subdivided the animals in two groups, under and up of the 1
year of age, and we found a low positivity only 1% in the subject under the year of age and
the gender ratio for susceptibility appear same between male and female 1.3:1 of all ages.
In the comparative study of the 140 cases, we examined the correlation between the
histological and the serological aspect of the same birds.
None of the 120 animals with crop histologicaly negative showed the positivity for all three
antibodies and the 85% presented a negativity for all three antigens, the 98% of the 30
seras obtained from symptomatic and histologically positive birds showed high antibody
titres at least one of three antigens. The most important data is that 70% of sera obtained
from these histological positive birds showed high antibody titres for all of three antigens in
particulary for parot’s gangliosides pool. About these 140 animals histologicaly and 
serologically tested, during the year 2008-2009 we had the opportunity to follow for a
period of 1 year the clinical status of 102 animal in an italian and spainsh breeding centers.
Of these parrots 89 presented negativity for both examination, 6 (1 Psittacula finschii, 1
Amazona rhodocorita, 1 Cacatua moluccensis, 1 Cacatua galerita, 2 Amazona
viridiginalis) presented a positivity for both aspects, 1 (Ara glaucogularis) was positive
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histologicaly and positive for 2 (GT1b , pool of gangliosides) of the three antigens, 7
(Psittacula krameri, Amazona ocrocephala, Pionus fuscus, Eclectus roratus, Amazona
farinosa, Cacatua alba) appeared histologicaly positive and negative subsequently the
serological examination and only 1 subject (Cacatua moluccensis) presented a not clear
signs of histological positivity with a very light perigangliar infiltration and show positive
value for GM1, dubt for GT1b and negative for ganglioside pool. The 88 of the 89 different
parots totaly negative, didn’t show any kind of symptomatical and radiological alterations. 
During the all period of examination, only one (Psittacula krameri) showed a scab and
ulcerative lesions round the beack, reduction of body condition, with apatia and
enlargement of proventriculum observed by a contrastographic study. The remission of the
clinical alterations occurred after a treatment of antibiotic (enrofloxacine) and NSAD
(meloxicam). The histological examination of crop biopsy evidenced a granulomatous
ingluvitis. The 6 totally positive presented in all the cases the typical symptomatic signs
correlate with the x-ray proventricular enlargement. After a period of one year from the first
examination, 5 of it died and the in vitam PDD diagnosis was confirmed during the
necropsy and by the subsequent histological evaluation. Only one of it (Amazona
viridiginalis) still alive after one year, even if present undigested food in the feces, very bad
feather condition and the enlargement of the proventriculum, furthermore a second
serological and histological examination continue to indicate a positive status for PDD.
The one cases (Ara glaucogularis) that demonstrated a positive evaluation for the
histology and for GT1b and gangliosides pool, died with the characteristic lesion and
clinical signs of PDD, the causes of the death was confirm by post mortem laboratory
examination; while the cases of Cacatua mollucensis with unclear situation after three
subsequent histological evaluations continue to demonstrate a border line mycroscopical
pattern even if the values of antibodies decrease and became negative, the animal never
shows during all the period of the study any clinic-pathological signs correlated with PDD.
Different development of the disease was observed in the parrots histologically positive
and serologically negative. The Psittacula krameri and the Amazona ocrocephala died
respectively after 2 and 30 days subsequently of the comparison of the clinical signs of the
disease, and the in vitam diagnosis was confirmed by the histology on the different sample
of the trigger organs, even if the amazon show very light lymphoplasmacitic infiltration of
adrenal glands and crop. The other 4 birds showed a remission of clinical signs
characterized by enlargement of proventriculum and gastrointestinal alterations present
both or alone. To confirm the PDD negativization of the patients, three subsequent session
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of crop biopsy with related histological examination and serological evaluation was made.
All results appeared negative and confirm the apparent recovery of the four subjects.
The 6 subjects of cockatiels (Nymphicus holladicus) inoculated by the extracted pool of
gangliosides, two weeks after the booster (1 month p.i.), 100% of I.P. inoculated and 33%
of orally challenged parrots developed typical PDD signs. Currently, four inoculated and
symptomatic cockatiels show typical ganglioneuritis in crop biopsies.
iiii) Conclusions and Discussion
In our study, we observed, for the first time, the correlation in PDD positive parrots of a
decrease number of PCNA positive cels into the basal layer of afected crop’s epithelium 
(Fig. 3), associate with a reduction in thickness of superficial pre-keratinized layer (Fig. 5).
Those may represent an unspecific early sign, strictly related to the dystrophic status of
the crop’s wal, generated by the non suppurative ganglioneuritis. The progressive and 
dramatic thinning and atrophy of the crop’s wal, sometime associated with the organ 
dilatation, could suggest to be a late consequence of these early histological alterations.
For what concern the periganglia infiltrate, our preliminary results demonstrate a high
percentage of CD3+ cells in the infiltrate, with large presence of CD8+ T cells and
macrophages in affected and symptomatic birds (Fig. 2). These immunophenotypic
findings correlate with morphologic data that indicate a microscopic changes characterized
by non suppurative ganglioneuritis with gliosis, cuffing, spots of demyelination and ganglia
swelling (photos ) (Graham, 1984; Joyner et al., 1989; Graham, 1991; Gregory et al.,
1996, Shivaprasad et al., 1997, Berhane et al., 2001), in our opinion, can suggest that an
immunomediate - autoimmune mechanism can be correlated with the pathogenesis of
histological lesions during the PDD processes.
The evidence of a seroprevalence of 70% in histologically and clinically positive parrots,
supported to the similar results obtained in experimental inoculated animals by ganglioside
extracting pool, confirms the possible roles of the antiganglosides antibodies in the
pathogenesis of PDD. The hight negativity correspondence of 85% between both
serological and histological tests show clearly how the low value of the blood
antigangliosides antibodies can be an indication of the healthy status of the examined
parrot. Moreover these evideces show the good predictivity of this non invasive test if
compared with the 60-70% of the diagnostic golden standard method rappresented by the
more invasive histological evaluation of crop biopsy.
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Furthermore even if the case histories is very low to extrapolated a reliable results, the 3 of
the 5 parrots (60%) that were histologically/clinically positive and serologically negative
after a period of 1 year have changed their PDD status begane apparently
(histologically/serologically/clinically) healthy animals. This observation appear very
interesting for different aspects: the first one is that none Authors have described any case
of recovery for this disease, and the second one, that the serological value can help the
clinician to formulated a future prognosis for an affected patient. To explain why the 40%
of this 5 parrots died rapidly (2-30 days) with low serological values we can formulate two
different hypotesis:
a high prevalence of a cell mediated immunoreaction to respect the humoral response
during the early phases of the lesion development
an acute and fastly lethal neural damage, induced by an unidentified neurotropic biological
agent, precluding a serological conversion or an effective cell mediated response before
the death.
Analising the serological results obtained from 1140 plasma samples is possible to see
haw the gender positivity confirm the same susceptibility of male and female described by
other Authors (Gregory, 1995; Phalen, 2006). Furthermore the rare increasing of the
antiganglioside antibodies values observed in the young subject is the same observed by
(Gregory, 1995; Phalen, 2006) by the histological examination. At the end the high 15%
and the low 2% relative positivity showed respectivetly by the “Group Cackatoo” and 
“Group Lory” reflect the natural susceptibility to this disease for of these genera like 
describe previously by (Gregory, 1995; Phalen, 2006). The highest relative value 23%
observed in the “Group Amazon” obtained to al appearance from healthy birds can be 
explained by a possible background interference induced by the hight level of lipoproteins
that normaly can be present in the plasma of these Genera.
In conclusion the autoimmune mechanism mediated by antiganglioside antibodies appear
very interesting, because places the proventricular dilatation disease PDD in the rare
group of the avian autoimmune diseases. These kind of pathologies even if described
more accurancy in the poultry not present a same equivalent disease in the avian exotic
medicine. Moreover this new and fascinating theory not exclude, but can complete, the
other aetiological hypotesis that saw in Avianbornavirus (Kistler et al., 2008, Honkavuori et
al., 2008, Gancz, et al.,2009, Liertz et al., 2009) or in other biological agents infection not
still recognized the causes of these disease like happened in subsequently of bacterial and
viral infections in human Guillain Barrè syndrome.
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Figure 6: Characteristic periganglia lymphoplasmacytic infiltrate (EE, 10X).
Figure 7: Characteristic periganglia lymphoplasmacytic infiltrate (EE, 20X).
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Figure 8: Cellular population in infiltrate, LinT C3+ in blu, macrophage in brown (IHC 40X).
Figure 9: Demyenlinization of crop nervous structure (LFB 40X).
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Figure 10: Reduce of thickness in pre-keratinized epithelial layer of the crop observed in
positive sample for PDD (DHTS10X).
Figure 11: Thickness in pre-keratinized epithelial layer of the crop observed in negative
sample for PDD (DHTS 10X).
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Figure 12: Reducing mitotic activity in basal crop epithelium observed in positive sample
for PDD (PCNA 10X).
Figure 13: Normal mitotic activity in basal crop epithelium observed in negative sample for
PDD (PCNA 10X).
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Figure 14: Antiganglioside extraction of CNS and PNS of parrots, the gangliosides (clear
matrix) separated from the other lipids (dark matrix) and the aqueous methanol phase
(upper liquid).
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